Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
“Ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)] is of considerable interest in light of its prosocial properties and risks associated with widespread recreational use. Recently, it was found to bind trace amine-1 receptors (TA 1 Rs), which modulate dopaminergic transmission. Accordingly, using mice genetically deprived of TA 1 R (TA 1-KO), we explored their significance to the actions of MDMA, which robustly activated human adenylyl cyclase-coupled TA 1 R transfected into HeLa cells. In wild-type (WT) mice, MDMA elicited a time-, dose-, and ambient temperature-dependent hypothermia and hyperthermia, whereas TA 1-KO mice displayed hyperthermia only. MDMA-induced increases in dialysate levels of dopamine (DA) in dorsal striatum were amplified in TA 1-KO mice, despite identical levels of MDMA itself. A similar facilitation of the influence of MDMA upon dopaminergic transmission was acquired in frontal cortex and nucleus accumbens, and induction of locomotion by MDMA was haloperidol-reversibly potentiated in TA 1-KO versus WT mice. Conversely, genetic deletion of TA 1 R did not affect increases in DA levels evoked by para-chloroamphetamine (PCA), which was inactive at hTA 1 sites. The TA 1 R agonist o-phenyl-3-iodotyramine (o-PIT) blunted the DA-releasing actions of PCA both in vivo(dialysis) and in vitro(synaptosomes) in WT but not TA 1-KO animals. MDMA-elicited increases in dialysis levels of serotonin (5-HT) were likewise greater in TA 1-KO versus WT mice, and 5-HT-releasing actions of PCA were blunted in vivo and in vitro by o-PIT in WT mice only. In conclusion, TA 1 Rs exert an inhibitory influence on both dopaminergic and serotonergic transmission, and MDMA auto-inhibits its neurochemical and functional actions by recruitment of TA 1 R. These observations have important implications for the effects of MDMA in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
A second class of chemosensory receptors in the olfactory epithelium
Liberles, S. D., & Buck, L. B. (2006) · Nature · doi:10.1038/nature05066 · Cited by 791 · cited 1×
“expressed in olfactory epithelium (Liberles and Buck, 2006), Received May 18, 2011; revised Sept.”
BackgroundAlterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572 · cited 1×
“, 2000b) and/or their protein partner, p11, to inhibit liberation of 5-HT (Svenningsson et al., 2006; Millan et al., 2008).”
BackgroundSelf-citationLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248 · cited 2×
“It would also be interesting to examine the influence of MDMA on prepulse inhibition (PPI) since MDMA disrupts sensorimotor gating in mice and humans (Vollenweider et al., 1999; Braff et al., 2001; Liechti et al., 2000), and PPI is blunted in TA1-KO versus WT mice (Wolinsky et al.”
BackgroundEffects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206 · cited 1×
“The monoamine releaser and reuptake suppressor, “ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)], facilitates prosocial behaviors in animals and humans (Bedi et al., 2009; Johansen and Krebs, 2009), actions related to enhanced release of oxytocin in centers controlling social behavior, like amygdala and septum (McG…”
BackgroundMcGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.132 · Cited by 171
Vollenweider, F. X., Remensberger, S., Hell, D., & Geyer, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050960 · Cited by 97
How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
Johansen, P., & Krebs, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102787 · Cited by 96 · cited 1×
“The monoamine releaser and reuptake suppressor, “ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)], facilitates prosocial behaviors in animals and humans (Bedi et al., 2009; Johansen and Krebs, 2009), actions related to enhanced release of oxytocin in centers controlling social behavior, like amygdala and septum (McG…”
Background
Cited by
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Trace Amines and Their Receptors
Gainetdinov, R. R., Hoener, M. C., & Berry, M. D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015305 · Cited by 384
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
Sitte, H. H., & Freissmuth, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.006 · Cited by 276
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Metadata
- Authors
- Di Cara, B., Maggio, R., Aloisi, G., Rivet, J.-M., Lundius, E. G., Yoshitake, T., Svenningsson, P., Brocco, M., Gobert, A., De Groote, L., Cistarelli, L., Veiga, S., De Montrion, C., Rodriguez, M., Galizzi, J.-P., Lockhart, B. P., Cogé, F., Boutin, J. A., Vayer, P., Verdouw, P. M., Groenink, L., & Millan, M. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-11-23
- Volume
- 31
- Issue
- 47
- Pages
- 16928-16940
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2105566727
- Cited by
- 97
- References
- 9
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.